UBS AG - TRANSITION THERAPEUTICS INC ownership

TRANSITION THERAPEUTICS INC's ticker is TTHI and the CUSIP is 893716209. A total of 17 filers reported holding TRANSITION THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS AG ownership history of TRANSITION THERAPEUTICS INC
ValueSharesWeighting
Q2 2014$24,000
+166.7%
3,538
+63.0%
0.00%
Q3 2013$9,000
+125.0%
2,171
+59.6%
0.00%
Q2 2013$4,0001,3600.00%
Other shareholders
TRANSITION THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 4,863,914$10,214,0001.24%
Birchview Capital, LP 145,746$306,0000.16%
DAFNA Capital Management LLC 59,222$124,0000.10%
HOLLENCREST CAPITAL MANAGEMENT 162,196$341,0000.05%
VESTOR CAPITAL, LLC 42,600$89,0000.03%
Plante Moran Financial Advisors, LLC 17,034$36,0000.03%
SABBY MANAGEMENT, LLC 302,837$636,0000.02%
SPHERA FUNDS MANAGEMENT LTD. 70,273$148,0000.01%
FineMark National Bank & Trust 22,807$48,0000.01%
Alyeska Investment Group, L.P. 394,858$830,0000.01%
View complete list of TRANSITION THERAPEUTICS INC shareholders